Climate Change Data Portal
| Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy | |
| 项目编号 | 5R01CA193532-02 |
| TESSEMA, MATHEWOS | |
| 项目主持机构 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RES |
| 开始日期 | 2016-03-01 |
| 结束日期 | 2021-02-28 |
| 英文摘要 | Packaging has improved the safety and quality of poultry products. Currently, MAP (Modified Atmosphere Packaging) is the most widely used packaging system. MAP seals fresh produce in a tray with a controlled atmosphere that contains gases that slow the degradation of the product. SCIENCEPACK has designed and developed an innovative “Regenerative Atmosphere Packing” (RAP) that offers an effective alternative to the conventional MAP system. The key to this innovation is that, thanks to a specific tray design and active coating (AC), CO2 is slowly released from the packaging. This allows the tray to regenerate the product preserving. FRESHRAP’s represents a huge opportunity for our company (SCIENCEPACK) to commercialise an innovative solution that will increase the shelf life, quality and the safety of fresh chicken parts. This offers us the opportunity to launch a new product on to the large and growing packaging tray market. FRESHRAP will promote the efficient use of resources and reduce food waste by extending 1-1.5 days the shelf-life of fresh chicken, and removing the need to dispose of opened, in-date chicken trays. 60% of Europeans throw away opened chicken meat, causing approximately 360,000 tonnes of waste per year in Europe. We offer the possibility to end this waste. FRESHRAP will also help to ensure that food remains safe to eat for longer, reducing the number of customers suffering from food contamination (Campylobacter). Finally, FRESHRAP will also support packaging companies by reducing the high capital and operational costs of MAP packaging. Initial market projections suggest that FRESHRAP will achieve sales of 5 million units in the first year of commercialisation, growing to 30 million by 2022, earning profits of over 2M€ and a ROI on project investment of 94%. |
| 学科分类 | 14 - 医学科学 |
| 资助机构 | US-NIH |
| 项目经费 | 535737 |
| 项目类型 | Non-SBIR/STTR RPGs |
| 国家 | US |
| 语种 | 英语 |
| 文献类型 | 项目 |
| 条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/73911 |
| 推荐引用方式 GB/T 7714 | TESSEMA, MATHEWOS.Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy.2016. |
| 条目包含的文件 | 条目无相关文件。 | |||||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [TESSEMA, MATHEWOS]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [TESSEMA, MATHEWOS]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [TESSEMA, MATHEWOS]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
